Breast Cancer: Mandy's Survivor Story

Patient Info: Mandy

Mandy said her doctor had declared the breast cancer in remission, and she continued hormone therapy.

Our Cancer StoriesRead more →

Stage I Breast Cancer: Sanjana's Patient Story

Patient Info: Sanjana | Stage I

Sanjana says she has completed treatment and continues monthly check-ups while managing lingering concerns about menopause and the effects of therapy.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Sarah's Survivor Story

Patient Info: Sarah | Stage II

Sarah says she is in remission and continues hormone therapy.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Yurley's Survivor Story

Patient Info: Yurley, Under 40 | Stage III

She reports that her breast cancer is in remission and that she continues hormone therapy.

Our Cancer StoriesRead more →

Colorectal Cancer: Li's Patient Story

Patient Info: Li Zong

Li Zong remained on chemotherapy and targeted therapy while considering future hospice and palliative care.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Ada's Survivor Story

Patient Info: Ada, Female, 50s | Stage III

Ada described herself as being in remission while continuing hormone therapy. Fear of relapse remained, but she was focusing on travel, healthier routines and time with loved ones.

Our Cancer StoriesRead more →

A R M

Patient Info: A R M | Stage III

They report that the colorectal cancer is in remission after surgery and chemotherapy.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Liliana's Patient Story

Patient Info: Liliana | Stage II

Liliana completed active treatment after her final round of injections on September 19, 2023, and continued focusing on recovery, psychological support, and family life.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Katie's Survivor Story

Patient Info: Katie, Female, Under 40 | Stage III

Biomarkers: Hormone-sensitive breast cancer; specific receptor results not otherwise reported

As of December 2021, Katie had no evidence of cancer at the 5-year treatment mark after Stage III hormone-sensitive breast cancer treatment and later had twins after ovarian function returned.

Cleveland ClinicRead more →

Long-term complete response to nivolumab after recurrent Stage IV gastric cancer

Patient Info: Anonymized, female, 70+ | Stage IV

Biomarkers: HER2-negative, PD-L1 CPS ≤1

Metastatic Site: peritoneum, distant lymph nodes

About 7 years after surgery and roughly 3 years after starting nivolumab, CT showed no recurrent nodules or enlarged lymph nodes. She remained on nivolumab with a complete clinical response, had regained weight and returned to work.

PubMed CentralRead more →

Ovarian Granulosa Cell Tumor Recurring 17 Years After Surgery

Patient Info: Anonymized, Female, 70+

Biomarkers: Weak oestrogen sensitivity

Complete resection was not possible, but debulking relieved pressure on surrounding structures and improved her quality of life. She then continued oncology care with palliative carboplatin and paclitaxel.

PubMed CentralRead more →

Stage III Invasive Lobular Carcinoma: Jacque's Patient Story

Patient Info: Jacque, Female | Stage III

Jacque was treated for Stage III ILC with chemotherapy, 2 lumpectomies, daily radiation, and ongoing Tamoxifen as of December 2021.

Lobular Breast Cancer AllianceRead more →

Metastatic Clear Cell Ovarian Cancer Complicated by Treatment-Related Sarcoidosis

Patient Info: Anonymized, Female, 60s | Stage Metastatic/Advanced

Metastatic Site: peritoneum

During a treatment holiday, biopsy and laboratory evaluation showed treatment-related sarcoidosis rather than ovarian-cancer spread in the enlarged lymph nodes. After prednisone, the sarcoidosis resolved and imaging showed no progression of the clear cell ovarian cancer; she remained clinically well 4 months later.

PubMed CentralRead more →

Gastric Cancer: Daniel's Patient Story

Patient Info: Daniel ‘Joe’ Einspahr, Male

Biomarkers: BRAC2 mutation

Joe returned to full-time work and continued follow-up scans every 6 months after treatment for the local recurrence.

MD AndersonRead more →

BRCA Breast Cancer: Christie's Patient Story

Patient Info: Christie Siebel, female, Under 40

Biomarkers: BRCA mutation

At the latest update, Christie was doing well and attending annual breast cancer follow-up visits.

MD AndersonRead more →

BRCA Ovarian Cancer: Christie's Patient Story

Patient Info: Christie Siebel, female

Biomarkers: BRCA mutation

At the latest update, Christie was doing well and having a CA125 blood test every 3 months for ovarian cancer follow-up.

MD AndersonRead more →

Stage IV Gastric Adenocarcinoma: Doran's Patient Story

Patient Info: Doran Barro, Female, 70+ | Stage IV

Metastatic Site: peritoneum|liver|lungs

Doran entered hospice on September 24 and died on September 30, 2014, about 5 months after diagnosis.

Gastric Cancer: Sundar's Survivor Story

Patient Info: Sundar Matpadi, 40s

Sundar reported no evidence of disease after treatment, while continuing J-tube nutrition and gradually regaining weight.

Stage IV Gastric Cancer: Ernie's Patient Story

Patient Info: Ernie Pierce, Male, 60s | Stage IV

He died on July 8, 2009, after living with Stage IV gastric cancer for about 15 months.

Gastric Adenocarcinoma: Alan's Patient Story

Patient Info: Alan Gorman, 50s

Alan was receiving further chemotherapy after surgery because lymph nodes were involved.

Stage IV Gastric Cancer: Buddy's Patient Story

Patient Info: Buddy (Bernard), Male, 70+ | Stage IV

Metastatic Site: adrenal gland

Buddy died on November 9, 2012, a little more than 3 months after diagnosis.

Mr. Knight

Patient Info: Mr. Knight, Male, 60s

About a month after completing 5 weeks of chemotherapy and radiation, he was beginning to improve but still faced a long recovery.

Stage IV Gastric Cancer: Karen's Patient Story

Patient Info: Karen Lucas, Female, 60s | Stage IV

Karen died peacefully at home on January 30, 2014, at age 62, a little over 1 year after her Stage IV diagnosis.

Immature Ovarian Teratoma Followed by Anti-NMDAR Encephalitis

Patient Info: Anonymized, Female

Biomarkers: AFP 67.6 ng/mL; CA-125 89 at presentation

After 4 cycles of chemotherapy, her neurological deficits fully recovered and she could walk independently, with mild stuttering improving through speech therapy.

PubMed CentralRead more →